A phase 2 trial assessing Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis – MODIF-MS
A phase 2 trial assessing Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis – MODIF-MS
What it found
Still running
No result yet.
Loading reviews and guidelines…
History
- Completion date changed from 2027-02-14 to 2031-08-27
Started
Aug 2024
Finished
Aug 2031
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error